title: The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
abstract: We determined the binding domains of sufentanil and lofentanil in the mu opioid receptor by comparing their binding affinities to seven mu/delta and six mu/kappa chimeric receptors with those to mu, delta and kappa opioid receptors. TMHs 6 and 7 and the e3 loop of the mu opioid receptor were important for selective binding of sufentanil and lofentanil to the mu over the kappa receptor. TMHs 1-3 and the e1 loop of the mu opioid receptor conferred binding selectivity for sufentanil over the delta receptor. Thus, the region that conferred binding selectivity for sufentanil differs, depending on chimeras used. In addition, the interaction TMHs 1-3 and TMHs 6-7 was crucial for the high affinity binding of these two ligands. These two regions are likely to contain sites of interaction with the ligands or to confer conformations specific to the mu receptor.
authors.affiliation: Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
authors.forename: J
authors.initials: J
authors.lastname: Zhu
authors.forename: J C
authors.initials: JC
authors.lastname: Xue
authors.forename: P Y
authors.initials: PY
authors.lastname: Law
authors.forename: P A
authors.initials: PA
authors.lastname: Claude
authors.forename: L Y
authors.initials: LY
authors.lastname: Luo
authors.forename: J
authors.initials: J
authors.lastname: Yin
authors.forename: C
authors.initials: C
authors.lastname: Chen
authors.forename: L Y
authors.initials: LY
authors.lastname: Liu-Chen
mesh_terms: D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D016466:CHO Cells; D006224:Cricetinae; D004174:Diprenorphine / Q000378:metabolism; D005283:Fentanyl / Q000031:analogs & derivatives / Q000378:metabolism; D007700:Kinetics; D011485:Protein Binding; D051381:Rats; D017465:Receptors, Opioid, delta / Q000737:chemistry / Q000378:metabolism*; D017473:Receptors, Opioid, kappa / Q000737:chemistry / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000737:chemistry / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D017409:Sufentanil / Q000378:metabolism*
chemical_list: D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D011993:Recombinant Fusion Proteins; D004174:Diprenorphine; C034846:lofentanil; D017409:Sufentanil; D005283:Fentanyl